Vial access device

DEVICE4 trials

Sponsors

Heron Therapeutics

Conditions

Postoperative Pain

Phase 2

Phase 2 Herniorrhaphy Study for Opioid Elimination

CompletedNCT03695367

Heron TherapeuticsPostoperative Pain

Start: 2018-10-01End: 2018-12-15Updated: 2026-03-02

Phase 2 Bunionectomy HTX-011 Administration Study

CompletedNCT03718039

Heron TherapeuticsPostoperative Pain

Start: 2018-10-24End: 2019-03-11Updated: 2026-03-02

Phase 3

Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2)

CompletedNCT03237481

Heron TherapeuticsPostoperative Pain

Start: 2017-07-31End: 2018-01-16Updated: 2026-03-02

Bunionectomy Study for Postoperative Analgesia (EPOCH 1)

CompletedNCT03295721

Heron TherapeuticsPostoperative Pain

Start: 2017-10-24End: 2018-03-13Updated: 2026-03-02

Related Papers

Opioid-Free Recovery After Hernia Repair with HTX-011 as the Foundation of a Non-Opioid, Multimodal Analgesia Regimen in a Real-World Setting: A Randomized, Open-Label Study.

2021-07-276 citations

HTX-011 Effectively Reduces Postoperative Pain Intensity and Opioid use in the Elderly

Pain Management2021-07-218 citations

HTX-011 reduced pain intensity and opioid consumption versus bupivacaine HCl in herniorrhaphy: results from the phase 3 EPOCH 2 study.

2019-08-1941 citations

HTX-011 reduced pain intensity and opioid consumption versus bupivacaine HCl in bunionectomy: phase III results from the randomized EPOCH 1 study

Regional Anesthesia & Pain Medicine2019-05-2152 citations